Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.
Caroline J Aalbers, Lisette Bevaart, Scott Loiler et al. · PLoS ONE · 2015
Abstract onlyNot checked